We have recently found that treatment with PDK1-specific inhibitors decreased anchorage-dependent and anchorage-independent growth of pancreatic cancer cell lines, and pancreatic tumor growth in a xenograft model [11]. The gene discussed is PDK1; the disease is familial pancreatic carcinoma.